Zinzino Group revenue increased with a total of 60% in Q1 compared with the previous year.
The revenue in March for Zinzino’s sales markets increased by 79% and amounted to SEK 268.0 (USD $149.7) million.
Faun Pharma’s external sales decreased and amounted to SEK 7.1 (USD $9.8 ) million.
Overall, the Group increased revenues by 72% to SEK 275.1 (USD $159.5) million compared with the previous year.
The group revenue increased with 60% for Q1 2025 compared with the first quarter last year and amounted to SEK 725.9 (USD $454.5) million.
Revenues were distributed as follows:
Regions, mSEK
25-Mar
24-Mar
Change
Q1 2025
Q1 2024
Change
The Nordics
26.4
23.0
15 %
77.0
68.1
13 % increase
Central Europe
71.1
41.7
71 %
197.9
119.5
66 % increase
East Europe
34.0
31.9
7 %
97.3
93.8
4 % increase
South & West Europe
43.8
25.6
71 %
126.1
70.6
79 % increase
The Baltics
9.7
7.8
24 %
28.9
23.8
21 % increase
North America
56.1
13.5
316 %
112.2
35.4
217 % increase
Asia-Pacific
24.8
5.0
396 %
65.3
12.4
427 % increase
Africa
2.1
1.2
75 %
5.1
3.3
55 % increase
Zinzino
268.0
149.7
79 %
709.8
426.9
66 % increase
Faun Pharma
7.1
9.8
-28 %
16.1
27.6
42 % decrease
Zinzino Group
275.1
159.5
72 %
725.9
454.5
60 % increase
Countries in Each Region:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden– Central Europe: Austria, Germany, Switzerland– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands– The Baltics: Estonia, Latvia, Lithuania– North America: Canada, USA, Mexico– Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand– Africa: South Africa
To read the Zinzino Preliminary Sales Report Q1 2025, please visit Zinzino.com
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in